Validation of key proteins suggests that ANXA2 can be a screening biomarker for both primary and secondary infertility, whereas CDC42 and SEMG2 can be useful candidate biomarkers for primary infertility and APP for secondary infertility. The gene discussed is APP; the disease is Infertility.